SCIE期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2024/2025影响因子:5.521 (CRIT REV ONCOL HEMAT) (1040-8428). (ONCOLOGY)(肿瘤学)Sc

显示全部楼层 · 发表于 2025-3-25 09:19:52

Submitted on: 17 January 2021. Revised on: 08 March 2021. Accepted on: 09 April 2021. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

显示全部楼层 · 发表于 2025-3-25 11:59:34

Submitted on: 28 December 2020. Revised on: 10 April 2021. Accepted on: 04 May 2021. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

显示全部楼层 · 发表于 2025-3-25 18:27:07

Submitted on: 22 December 2019. Revised on: 29 March 2020. Accepted on: 13 April 2020. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

显示全部楼层 · 发表于 2025-3-25 22:23:05

Submitted on: 17 June 2013. Revised on: 14 July 2013. Accepted on: 04 August 2013. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

显示全部楼层 · 发表于 2025-3-26 03:24:57

Submitted on: 18 July 2007. Revised on: 25 September 2007. Accepted on: 02 November 2007. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

显示全部楼层 · 发表于 2025-3-26 08:13:04

Submitted on: 23 September 2024. Revised on: 14 November 2024. Accepted on: 29 November 2024. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

显示全部楼层 · 发表于 2025-3-26 08:36:05

显示全部楼层 · 发表于 2025-3-26 15:22:30

显示全部楼层 · 发表于 2025-3-26 18:43:52

Submitted on: 18 October 2004. Revised on: 15 December 2004. Accepted on: 02 January 2005. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-5 07:37
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

SCIE期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2024/2025影响因子:5.521 (CRIT REV ONCOL HEMAT) (1040-8428). (ONCOLOGY)(肿瘤学)Sc

浏览过的版块